HLB GenexHLB제넥스
187420 · KOSDAQ · ₩187420 · HLB제넥스
₩2,255▼ ₩45 (1.96%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩43B | ₩35B | ₩27B | ₩28B | ₩26B |
| Cost of sales | ₩28B | ₩21B | ₩20B | ₩18B | ₩16B |
| Gross profit | ₩15B | ₩14B | ₩7.3B | ₩10B | ₩9.8B |
| Operating income | ₩1.2B | −₩1.9B | −₩9.5B | −₩6.2B | −₩3.8B |
| Net income | ₩23B | −₩18B | −₩722M | −₩13B | −₩8.5B |
| Net income to shareholders | ₩23B | −₩19B | −₩3B | −₩13B | −₩6.8B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩136B | ₩146B | ₩98B | ₩134B | ₩119B |
| Current assets | ₩50B | ₩97B | ₩43B | ₩55B | ₩37B |
| Cash and equivalents | ₩33B | ₩84B | ₩23B | ₩11B | ₩6.1B |
| Total liabilities | ₩81B | ₩118B | ₩72B | ₩107B | ₩80B |
| Current liabilities | ₩63B | ₩91B | ₩60B | ₩94B | ₩52B |
| Borrowings | ₩4.6B | ₩7.2B | ₩51B | ₩66B | ₩32B |
| Total equity | ₩55B | ₩28B | ₩26B | ₩27B | ₩39B |
| Shareholders' equity | ₩41B | ₩24B | ₩22B | ₩24B | ₩35B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩3.5B | ₩2.9B | −₩4.8B | −₩4.7B | −₩2.4B |
| Capital spending | −₩822M | −₩649M | ₩1.2B | — | — |
| Free cash flow | ₩2.7B | ₩2.2B | −₩6B | −₩4.7B | −₩2.4B |
Consolidated where available. Amounts in won.
Also known as: HLB Genex / HLB제넥스 / 187420 / KRX:187420
Source: KRX statistical information